Cargando…
A randomized, double-blind, placebo-controlled phase 2 study of intratympanic OTO-313 in patients with moderate to severe subjective tinnitus
PURPOSE: This was a randomized, double-blind, placebo-controlled Phase 2 study to evaluate the efficacy and safety of intratympanic OTO-313 in patients with subjective unilateral tinnitus. METHODS: Patients with moderate to severe unilateral tinnitus of 2–12 months duration were enrolled. A single i...
Autores principales: | Searchfield, Grant D., Robinson, James M., Skarinsky, David, Wang, Yiwei, Anderson, Jeffery J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620247/ https://www.ncbi.nlm.nih.gov/pubmed/37341760 http://dx.doi.org/10.1007/s00405-023-08047-0 |
Ejemplares similares
-
Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study
por: Maxwell, Kenneth S., et al.
Publicado: (2021) -
Efficacy of Intratympanic OTO-104 for the Treatment of Ménière's Disease: The Outcome of Three Randomized, Double-Blind, Placebo-Controlled Studies
por: Phillips, John, et al.
Publicado: (2023) -
Safety of Repeated-Dose Intratympanic Injections with AM-101 in Acute Inner Ear Tinnitus
por: Staecker, Hinrich, et al.
Publicado: (2017) -
Intratympanic gentamycine for Ménière’s disease: is there a selective vestibulotoxic effect?
por: Molnár, András, et al.
Publicado: (2020) -
Duration of symptom control following intratympanic dexamethasone injections in Meniere’s disease
por: Hilton, Aidan, et al.
Publicado: (2022)